HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study. Chang X, Li X, Sun P, Li Z, et al. BMC Cancer 2024;24:480.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chang X, Li X, Sun P, Li Z, et al. HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study. BMC Cancer 2024;24:480.
PMID: 38627684